|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1990-9-17
|
|
pubmed:abstractText |
Gadopentetate dimeglumine (Gd-DTPA) was injected into an anephric patient on maintenance haemodialysis. Sequential serum Gd levels before and after dialysis demonstrated incomplete removal of the administered dose. No clinical sequelae were observed. Gd-DTPA can be given to patients on dialysis, but like iodinated contrast media, may require more than one session for complete removal.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0009-9260
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
430-2
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2383962-Adult,
pubmed-meshheading:2383962-Brain Neoplasms,
pubmed-meshheading:2383962-Brain Stem,
pubmed-meshheading:2383962-Gadolinium,
pubmed-meshheading:2383962-Gadolinium DTPA,
pubmed-meshheading:2383962-Hemangiosarcoma,
pubmed-meshheading:2383962-Humans,
pubmed-meshheading:2383962-Image Enhancement,
pubmed-meshheading:2383962-Magnetic Resonance Imaging,
pubmed-meshheading:2383962-Male,
pubmed-meshheading:2383962-Nephrectomy,
pubmed-meshheading:2383962-Organometallic Compounds,
pubmed-meshheading:2383962-Pentetic Acid,
pubmed-meshheading:2383962-Renal Dialysis
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Gadopentetate dimeglumine enhanced MRI in an anephric patient on dialysis.
|
|
pubmed:affiliation |
Diagnostic Radiology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
